CALC
HealthcareCalciMedica, Inc.
$6.01
$-0.73 (-10.83%)
Jan 5, 2026
Price History (1Y)
Analysis
CalciMedica, Inc. is a biotechnology company operating within the healthcare sector. The company has a relatively small scale with 15 employees and a market capitalization of $86.60M. Financially, CalciMedica appears to be unprofitable, with gross margins, operating margins, and profit margins all at 0.0%. Returns on equity and assets are also negative, at -526.4% and -100.0%, respectively. The company has a cash balance of $14.08M but debt of $8.90M, resulting in a current ratio of 4.04. The valuation of CalciMedica is notable for its negative P/E ratio (-3.69) and price to book ratio (-316.32), indicating significant losses or other factors affecting the company's financials. The forward P/E ratio is also negative (-3.70). Dividend information is not available, and growth rates are N/A due to unreported revenue and earnings data.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About CalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.
Visit website →Key Statistics
- Market Cap
- $86.60M
- P/E Ratio
- N/A
- 52-Week High
- $7.20
- 52-Week Low
- $1.42
- Avg Volume
- 79.40K
- Beta
- 0.89
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 15